Seeking Alpha
22 Nov 2026, 03:47 UTC · 33m ago
Prenetics: The Selloff Priced In The Spend, Not The Payback
Impact · against what's priced in
Prenetics is positioned for a recovery based on a projected 3-to-1 gross profit return on acquisition costs by 2027. While strong Q3 revenue growth is evident, the market has already discounted the immediate drag of increased EBITDA losses from aggressive spending.
- PRE+0.40
No priced-in read yet
- In context
Q3 revenue growth of 3.3x to $64.1 million and a targeted 3-to-1 gross profit return by 2027 provide a bullish outlook, though near-term EBITDA losses have already pressured the stock.
Read from the article alone





